Liquid biopsy, big data and artificial intelligence as a new global clinical trial model in targeted therapy
{{output}}
To this day, the phase III trial continues to be, as it was more than 60 years ago, the standard for the incorporation of new treatments in oncology. We currently have new tools such as NGS, Liquid Biopsy (LB), Big Data (BD) and Artificial Intelligence (AI) th... ...
